Concepedia
Statistics
Publications
17
Citations
1.4K
H-Index
15
Active since
1994
Affiliations
Johns Hopkins Medicine(Current)
Johns Hopkins University
Changhai Hospital
Johns Hopkins Hospital
Second Military Medical University
Li Weng is an author at Johns Hopkins Medicine specializing in medicine, oncology, and molecular biology.
Publications per year
1994–2023
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
Joaquín Martínez‐López, Juan José Lahuerta, François Pépin et al. · Blood · 2014 · 427 citations · Full text
Medicine, Hematology, Oncology +17
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 309 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.
Steven D. Gore, Li Weng, S. Zhai et al. · PubMed · 2001 · 102 citations
Medicine, Pharmacology, Pharmacotherapy +14
Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection
Li Weng, Juan Du, Qing-Hui Zhou et al. · Molecular Cancer · 2012 · 84 citations · Full text
Medicine, Molecular Biology, Oncology +17
Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells.
Steven D. Gore, Dvorit Samid, Li Weng · PubMed · 1997 · 75 citations
Medicine, Oncology, Pharmacology +15
1–5 of 17